Vietnam's National Assembly admitted a proposal to remove barriers to foreign investment in healthcare on 1 September 2016. This could open up sectors like laboratory services and cosmetic surgery.
Private medical insurers face colossal problems in China, India and across South East Asia. At this month’s Asia Healthcare Summit in Singapore, they were better at describing the challenges of culture, fraud and overtreatment than they were at coming up with solutions.
The Malaysian primary care chain, Qualitas Health, is looking at Myanmar and Vietnam as part of its expansion plans. Executive director, Kharim Dhala, told Healthcare Nova his CFO is currently looking at opportunities.
Between 2009 and 2014, the Chinese government spent over $370bn on healthcare, three times the $124bn initially planned. It is now drafting a new set of reforms in its new five-year road map to 2020, by which time total healthcare spending is expected to reach $1 trillion according to McKinsey.
One of the largest private hospital operators in Vietnam plans to open an international hub and spoke model by building 15 primary care outpatient clinics in Vietnam, Cambodia, Laos and Myanmar.
Approximately 15% of the population already use private healthcare in Thailand and domestic hospital groups are enjoying a universal healthcare coverage inspired renaissance. What are the main drivers? Where is the market going? And will foreign groups be enticed in by these rich pickings? John Low gives his insights.
Nestled between the giant Indian, Chinese and Malaysian markets, Thailand has long passed under the radar. No more. Public health reform and aging populations have spurred rapid growth. And no longer content with medical tourists, its highly profitable hospital groups are moving abroad. Can these dark horses take advantage of the integration of ASEAN and become the dominant force in the region?
Bumrungrad is a world leader in medical tourism and has effectively leveraged Thailand’s many advantages in this sector. Unlike its competitors, it has focused on high-end tertiary care from a single campus. Narasimhan leads us through the history of the group, the secret to profit margins of 20%, the changing dynamics of medical tourism and the future of the Thai market.
Singapore-based private equity firm Quadria Capital has raised $304m toward healthcare investments in South East and South Asia. Abrar Mir, managing partner at Quadria Capital, explains why the region is so attractive to investors.
In March 2015, China rescinded plans to allow private operators to be 100% owned by outsiders. Some operators complain that they face huge barriers. Yet China still plans a massive expansion in private beds. What is the true picture and what is the future likely to hold?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
